GB1223444A - Substituted endoethenocodides and morphides - Google Patents

Substituted endoethenocodides and morphides

Info

Publication number
GB1223444A
GB1223444A GB08457/68A GB1845768A GB1223444A GB 1223444 A GB1223444 A GB 1223444A GB 08457/68 A GB08457/68 A GB 08457/68A GB 1845768 A GB1845768 A GB 1845768A GB 1223444 A GB1223444 A GB 1223444A
Authority
GB
United Kingdom
Prior art keywords
formula
alkyl
compounds
group
represents hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08457/68A
Inventor
John Johnston Brown
Robert Allis Hardy Jr
Carol Therese Nora
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of GB1223444A publication Critical patent/GB1223444A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1,223,444. Endoethenonorcodes and normorphides. AMERICAN CYANAMID CO. 26 April, 1968 [27 April, 1967], No. 18457/68. Heading C2C. The invention comprises compounds of the Formula I where R 1 represents hydrogen, C 1-4 alkyl, or C 2-5 alkanoyl, R 2 represents hydrogen, cyano, propargyl, C 1-4 alkyl, phenyl-C 1-4 alkyl, C 2-6 alkenyl or C 4-7 cycloalkylmethyl, such that when R 1 represents C 1-4 alkyl, R 2 represents C 4-7 cycloalkylmethyl, R 3 represents hydrogen, phenyl, or C 1-8 alkyl and Y represents ethano or etheno or non-toxic pharmaceutically acceptable acid addition salts thereof or alkali metal phenolates, where R 1 represents hydrogen and their preparation by treating a compound of the Formula II, where Z represents a group of the Formula IIA, R 4 represents C 1-4 alkyl, R 5 represents hydrogen or C 1-7 alkyl and n is 2 or 3 with dilute aqueous acid at 0-100‹ C. and if desired forming a salt of the product. Ketals of the Formula II may be prepared from appropriate compounds of the Formula I by reaction with an alcohol and a suitable acid. Enol ethers of the Formula II may be obtained by heating compounds of the Formula II where Z represents a group of the formula above its melting point. In compounds of the Formula II, thus produced, the 3-ether group may be converted to the free hydroxy group and the latter etherified to give a R 1 O-group and the N-substituent may be removed, e.g. by reaction with a cyanogen halide, the resulting N-cyano compound hydrolysed to a norcodide (R 2 =H) and the latter alkylated directly or by acylation and reduction of the resulting acylamino compound. Therapeutic compositions having analgesic or anti-nociperceptive properties for oral and parenteral administration comprise the compounds of the invention together with a suitable carrier.
GB08457/68A 1967-04-27 1968-04-26 Substituted endoethenocodides and morphides Expired GB1223444A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63411667A 1967-04-27 1967-04-27

Publications (1)

Publication Number Publication Date
GB1223444A true GB1223444A (en) 1971-02-24

Family

ID=24542502

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08457/68A Expired GB1223444A (en) 1967-04-27 1968-04-26 Substituted endoethenocodides and morphides

Country Status (10)

Country Link
AT (1) AT289303B (en)
BE (1) BE714349A (en)
CH (1) CH507250A (en)
DE (1) DE1770287A1 (en)
ES (1) ES353268A1 (en)
FR (2) FR1589058A (en)
GB (1) GB1223444A (en)
IL (1) IL29798A0 (en)
LU (1) LU55980A1 (en)
NL (1) NL6805648A (en)

Also Published As

Publication number Publication date
DE1770287A1 (en) 1971-10-21
BE714349A (en) 1968-10-28
ES353268A1 (en) 1970-02-01
LU55980A1 (en) 1968-07-12
IL29798A0 (en) 1968-06-20
FR7483M (en) 1969-12-01
NL6805648A (en) 1968-10-28
FR1589058A (en) 1970-03-23
CH507250A (en) 1971-05-15
AT289303B (en) 1971-04-13

Similar Documents

Publication Publication Date Title
KR920008026A (en) Isoquinolinone derivatives or nontoxic acid addition salts thereof or hydrates thereof, methods for preparing the same, and pharmaceutical compositions comprising the same
ES482323A1 (en) Cephem compounds, processes for their preparation and pharmaceutical compositions containing them.
GB1102934A (en) A process for the manufacture of benzdiaz[1,4]epine derivatives
GB1335492A (en) Cyclocytidine compounds and process for making same
GB1222286A (en) BENZ[e]INDENE AND PHENANTHRENE DERIVATIVES AND A PROCESS FOR THE MANUFACTURE THEREOF
GB1173227A (en) Amino-Isoquinolines
GB1223444A (en) Substituted endoethenocodides and morphides
GB1173221A (en) Substituted 6,7-Benzomorphans and their Preparation
GB1053843A (en)
GB997637A (en) Substituted 2-cyclopropylmethyl-6,7-benzmorphans
GB1224530A (en) Indolyltetrahydropyridines
GB1123768A (en) New thebaine and oripavine derivatives and processes for preparing the same
GB1112087A (en) New pyridazone derivatives and process for preparing same
GB1095912A (en) Trans indolomorphinans and preparation thereof
GB1035447A (en) 1-substituted yohimbanes
GB1233943A (en)
GB1086101A (en) New chromans and process for preparing same
GB1060069A (en) Improvements in or relating to phenylethanolamines
GB1298284A (en) Preparation of phenylaminoethanols
SE324562B (en)
GB1199862A (en) A Process for the Manufacture of Dihydro-Benzdiaz[1,4]Epines
GB1264944A (en)
GB1246469A (en) Pharamaceutical compositions of 4-phenylbicyclo[2.2.2]-octane, and oct-2-ene, -1-carboxylates and methods of using same
GB971042A (en) New benzotriazole derivatives
GB1079258A (en) 19-nor-progesterone derivatives